Concepedia

Scott E. Delacroix

SE

Statistics

Publications

21

Citations

1.2K

H-Index

15

Active since

2010

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Louisiana State University Health Sciences Center New Orleans

Louisiana State University

Mayo Clinic in Arizona

Johns Hopkins University

Scott E. Delacroix is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and surgery.

ORCID

Publications per year

2010–2024

21

Publications

21

The Impact of Targeted Molecular Therapies on the Level of Renal Cell Carcinoma Vena Caval Tumor Thrombus

Nicholas G. Cost, Scott E. Delacroix, Joshua Sleeper et al. · European Urology · 2011 · 210 citations

, , +9

Urinary Tract Injures: Recognition and Management

Scott E. Delacroix, J. Christian Winters · Clinics in Colon and Rectal Surgery · 2010 · 166 citations · Full text

, , +17

Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery in Patients with High Grade Upper Tract Urothelial Carcinoma

Vitaly Margulis, Mäneka Puligandla, Edouard J. Trabulsi et al. · The Journal of Urology · 2019 · 133 citations · Full text

, , +16

Safety of Presurgical Targeted Therapy in the Setting of Metastatic Renal Cell Carcinoma

Brian F. Chapin, Scott E. Delacroix, Stephen H. Culp et al. · European Urology · 2011 · 102 citations

, , +14

Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study

Mohamad E. Allaf, Se-Eun Kim, Viraj A. Master et al. · The Lancet Oncology · 2024 · 82 citations · Full text

, , +10

1–5 of 21